Venture Visionary Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
694
+5
| +0.7% | +$2.23K | 0.01% | 474 |
|
|
2025
Q1 | $334K | Sell |
689
-1
| -0.1% | -$485 | 0.01% | 445 |
|
|
2024
Q4 | $278K | Buy |
690
+4
| +0.6% | +$1.61K | 0.01% | 461 |
|
|
2024
Q3 | $319K | Sell |
686
-1
| -0.1% | -$465 | 0.01% | 445 |
|
|
2024
Q2 | $322K | Buy |
687
+14
| +2% | +$6.56K | 0.01% | 447 |
|
|
2024
Q1 | $281K | Sell |
673
-9
| -1% | -$3.76K | 0.01% | 455 |
|
|
2023
Q4 | $277K | Buy |
682
+10
| +1% | +$4.07K | 0.01% | 438 |
|
|
2023
Q3 | $234K | Sell |
672
-4
| -0.6% | -$1.39K | 0.01% | 440 |
|
|
2023
Q2 | $238K | Sell |
676
-5
| -0.7% | -$1.76K | 0.01% | 449 |
|
|
2023
Q1 | $215K | Buy |
+681
| New | +$215K | 0.01% | 461 |
|
|
2022
Q3 | – | Sell |
-339
| Closed | -$95.5K | – | 1521 |
|
|
2022
Q2 | $95.5K | Buy |
+339
| New | +$95.5K | 0.01% | 618 |
|